🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomised, controlled, open, two-armed, two-period cross-over, m...
Status
Completed
Location
Multiple Locations
Start Date
2007-08-21
Trial ID
NCT00915343
Treatments Being Tested
The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg ...
Status
Completed
Location
Simbec Research Ltd (Simbec)
Start Date
2018-06-11
Trial ID
NCT07173738
Treatments Being Tested
The present randomized-controlled pilot trial will test the feasibility, ac...
Status
Terminated
Location
Arizona State University
Start Date
2023-03-20
Trial ID
NCT05581849
Treatments Being Tested
This study seeks to understand the performance of MRI to characterize pancr...
Status
Enrolling By Invitation
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-18
Trial ID
NCT05659147
To investigate the effects of the pelvic floor and abdominal muscle trainin...
Status
Completed
Location
Gazi University
Start Date
2018-11-28
Trial ID
NCT05549193
Treatments Being Tested
In previous studies, investigators have studied if a pre-meal insulin bolus...
Status
Completed
Location
Institut de recherches cliniques de Montréal
Start Date
2016-06
Trial ID
NCT02798250
This A Three-Part Drug-Drug Interaction Study To Evaluate Effects of Casopi...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-23
Trial ID
NCT00511823
Treatments Being Tested
The primary objective of this trial is to assess the effects of cytisinicli...
Status
Completed
Location
BlueClinical Phase I
Start Date
2022-10-17
Trial ID
NCT05566288
Treatments Being Tested
The main goal of this trial is to evaluate the safety and tolerability of C...
Status
Recruiting
Location
Shanghai Mengchao Cancer Hospital
Start Date
2024-03-07
Trial ID
NCT06327997
Treatments Being Tested
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404